• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JMIR Public Health Surveill . Estimating the Epidemic Size of Superspreading Coronavirus Outbreaks in Real Time: Quantitative Study

tetano

Editor, Senior Moderator
JMIR Public Health Surveill


. 2024 Feb 12:10:e46687.
doi: 10.2196/46687. Estimating the Epidemic Size of Superspreading Coronavirus Outbreaks in Real Time: Quantitative Study

Kitty Y Lau[SUP] 1 2 [/SUP], Jian Kang[SUP] 2 [/SUP], Minah Park[SUP] 3 [/SUP], Gabriel Leung[SUP] 1 2 [/SUP], Joseph T Wu[SUP] 1 2 4 [/SUP], Kathy Leung[SUP] 1 2 4 [/SUP]



Affiliations
Abstract

Background: Novel coronaviruses have emerged and caused major epidemics and pandemics in the past 2 decades, including SARS-CoV-1, MERS-CoV, and SARS-CoV-2, which led to the current COVID-19 pandemic. These coronaviruses are marked by their potential to produce disproportionally large transmission clusters from superspreading events (SSEs). As prompt action is crucial to contain and mitigate SSEs, real-time epidemic size estimation could characterize the transmission heterogeneity and inform timely implementation of control measures.
Objective: This study aimed to estimate the epidemic size of SSEs to inform effective surveillance and rapid mitigation responses.
Methods: We developed a statistical framework based on back-calculation to estimate the epidemic size of ongoing coronavirus SSEs. We first validated the framework in simulated scenarios with the epidemiological characteristics of SARS, MERS, and COVID-19 SSEs. As case studies, we retrospectively applied the framework to the Amoy Gardens SARS outbreak in Hong Kong in 2003, a series of nosocomial MERS outbreaks in South Korea in 2015, and 2 COVID-19 outbreaks originating from restaurants in Hong Kong in 2020.
Results: The accuracy and precision of the estimation of epidemic size of SSEs improved with longer observation time; larger SSE size; and more accurate prior information about the epidemiological characteristics, such as the distribution of the incubation period and the distribution of the onset-to-confirmation delay. By retrospectively applying the framework, we found that the 95% credible interval of the estimates contained the true epidemic size after 37% of cases were reported in the Amoy Garden SARS SSE in Hong Kong, 41% to 62% of cases were observed in the 3 nosocomial MERS SSEs in South Korea, and 76% to 86% of cases were confirmed in the 2 COVID-19 SSEs in Hong Kong.
Conclusions: Our framework can be readily integrated into coronavirus surveillance systems to enhance situation awareness of ongoing SSEs.

Keywords: COVID-19; MERS; Middle East respiratory syndrome; SARS; SSE; coronavirus; coronavirus disease 2019; epidemic size; severe acute respiratory syndrome; superspreading event.

 
Back
Top Bottom